ALTO
Alto Ingredients, Inc.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$3.49
+1.16%Year over year
Reported trailing growth
- Revenue
- +1.1%
- EBITDA
- +341.2%
- EBIT
- +169.0%
- EPS
- +174.4%
- Free cash flow
- +481.7%
- Operating cash flow
- +731.1%
Forward estimates
Based on analyst estimates
- Revenue
- +4.4%
- EBITDA
- -7.8%
- EPS
- -44.4%
Three-year CAGR
- Revenue
- -11.8%
- EBITDA
- +333.0%
- EBIT
- +113.8%
- Net income
- +122.6%
- EPS
- +119.5%
- Free cash flow
- +159.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026